Colorite to Unveil TPE Compounds for Medical Devices at MD&M East

May 15 2017

A new line of thermoplastic elastomer (TPE) compounds for medical device applications in North America will be featured by Colorite, a Tekni-Plex company, at MD&M East, June 13-15, Jacob Javits Convention Center, New York City, in Booth 1445.

Cellene TPE compounds are suitable for a wide variety of uses in medical devices, packaging and other regulated markets. Cellene compounds are formulated to be silicone, latex, phthalate, halogen and PVC-free using FDA-compliant raw materials to meet USP Class VI and ISO 10993 standards.

For identifying growth opportunities in the global automotive thermoplastic resin composites market, please visit
http://www.lucintel.com/thermoplastic_resin_in_automotive_composites.aspx

Lucintel Corporate Customers

Market Entry, M & A, Opportunity Screening,...

Private Equity Customers

Buy Side Services (target screening, due diligence, ..)

Market Research Reports

Aerospace & Defense [52]
Chemical [146]
Composites & Advanced Materials [123]
Construction & Industrial [59]
Consumer and Retail [91]
Economic Analysis [86]
Energy & Utility [72]
Finance & Services [10]
Healthcare [31]
Media & Entertainment [16]
Metals & Mining [17]
Technology & Telecommunication [64]
Transportation [93]

Customer Quotes

"With more than 20 years experience in the industry, this is the first time we have come across such an extensive market analysis for our industry." Ven Cote, CEO, ZCL

"The insights we gained from Lucintel work helped with our business plan…a wonderful professional job…" Mike Jackson, Stahlin

"The report from Lucintel is useful not only for business planners, but also for the technology officers wanting to create a roadmap …" Dr. Giulio Ranzo, Booz Allen

"The information is so comprehensive, it has allowed us to identify & focus our business development efforts. It saved months of leg-work." Bill Barz, L&L Products

"We bought Lucintel report because it is the best report about our industry…a complete and appropriate analysis." Cesare Andrenacci, Ferretti

Quick Query

Lucintel Insights in News

Follow us on